European regulators green light new Alzheimer's drug

European regulators green light new Alzheimer's drug after first rejecting it
European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews
European watchdog partially approves new Alzheimer's drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
European Committee Takes a Second Look at Alzheimer's Drug and Now Says It Should Be Approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with early Alzheimer's disease, nearly four months after it first rejected the treatment.
EU regulator reverses decision to block Alzheimer's drug lecanemab
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at slowing cognitive decline in patients. In July, the Amsterdam-based European Medicines Agency (EMA) denied recommending approval of the drug made by Eisai and Biogen because it considered the risks - especially bleeding and swelling in the brain - to be greater than the potential benefits in a broad population.
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.
EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with early Alzheimer's disease, months after the agency first rejected the treatment.
El Mundo on MSN2d
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming years
However, there are more biological drugs targeting beta-amyloid in research, and many other treatments in clinical ...
earth3d
Herbal medicine shows great potential in treating and preventing dementia
Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.
Medscape7h
Managing Diabetes and Dementia in Long-Term Care
Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...
Alzheimer’s caregivers need updated drug rules to give families more time and peace | Opinion
Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...
New Atlas5d
Alzheimer’s drug trial raises concerns for accelerating cognitive decline
While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...
EurekAlert!8d
Chinese herbal medicine’s potential in preventing dementia
Osaka Metropolitan University researchers have found that administering the dried seeds of a type of jujube called Ziziphus ...
How Cannabis Is Changing Dementia Care For Patients And Families
Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...
Cholesterol fluctuations may be a tell-tale sign of dementia
Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.
Science Daily3d
Dementia News
For the first time, scientists have developed a drug that works on ... Dementia Diagnostic Markers Change With Time of Day Oct. 2, 2024 — The time of day when blood is taken can affect the ...
yourlifechoices.com.au1d
Is it dementia or normal brain ageing?
As people age, the body changes as part of the normal ageing process, such as greying hair and loss of elasticity in the skin ...